ACTY116 is a peptide designed to mimic the carboxyl terminus of Gαq protein [5,6], which can inhibit Gαq-mediated signal transduction and attenuate or reverse cardiac hypertrophy induced by pressure overload. Here, GNAQ is linked to cardiac hypertrophy.